NIFE PAR
Pharmaceutical form: Oral solution 30 ml
Active principle: Hospital product based in Nifedipine 5mg/ml in oral solution.
Approved indication
One flask is equivalent to a whole treatment
Description: To delay imminent preterm delivery in pregnant women.
-Easier to administrate: Flexibility according to response
-Quicker absorption rate (better bioavailability) and lower variability
-Better safety profile versus nifedipine capsules